NinjaDaddy personal page - To The Moon

NinjaDaddy

No personal profile

6Follow

0Followers

0Topic

0Badge

08-21

$Clover Health Corp(CLOV)$ Bullish

08-06

This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine

Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range

07-27

It's just another day to buy the dip

2023-11-07

Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m. The revision is an improvement.

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4143078149508732","uuid":"4143078149508732","gmtCreate":1679976194359,"gmtModify":1682738052859,"name":"NinjaDaddy","pinyin":"ninjadaddy","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"LV3 头像框","vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.06","exceedPercentage":"80.27%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.05","exceedPercentage":"93.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.05","exceedPercentage":"93.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":6,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":340623523848440,"gmtCreate":1724202206089,"gmtModify":1724202233214,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLOV\">$Clover Health Corp(CLOV)$</a>&nbsp; Bullish","listText":"<a href=\"https://ttm.financial/S/CLOV\">$Clover Health Corp(CLOV)$</a>&nbsp; Bullish","text":"$Clover Health Corp(CLOV)$ Bullish","images":[{"img":"https://community-static.tradeup.com/news/3884807ec615526a70577bd7facc5686","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/340623523848440","isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":335496080683016,"gmtCreate":1722944384940,"gmtModify":1722951516614,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine&nbsp;","listText":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine&nbsp;","text":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335496080683016","repostId":"2457089410","repostType":2,"repost":{"id":"2457089410","kind":"highlight","pubTimestamp":1722904917,"share":"https://ttm.financial/m/news/2457089410?lang=&edition=fundamental","pubTime":"2024-08-06 08:41","market":"hk","language":"en","title":"Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2457089410","media":"seekingalpha","summary":"Clover Health Investments  pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance. The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.  Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/CLOV\">Clover Health Investments</a> pleased investors after Monday&#39;s closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.</p><p>Shares of Clover Health gained over 2% in extended trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5a9c5d84fe8a57d68592d976038341cf\" tg-width=\"847\" tg-height=\"621\"/></p><p>The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.</p><p>Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-06 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.Shares of Clover ...</p>\n\n<a href=\"https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp","BK4547":"WSB热门概念","BK4154":"管理型保健护理"},"source_url":"https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2457089410","content_text":"Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.Shares of Clover Health gained over 2% in extended trading.The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.","news_type":1},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":332074973077536,"gmtCreate":1722080926059,"gmtModify":1722086434655,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"It's just another day to buy the dip","listText":"It's just another day to buy the dip","text":"It's just another day to buy the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/332074973077536","isVote":1,"tweetType":1,"viewCount":271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":238880686616664,"gmtCreate":1699349660119,"gmtModify":1699350799142,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m.&nbsp; The revision is an improvement.&nbsp;","listText":"Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m.&nbsp; The revision is an improvement.&nbsp;","text":"Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m. The revision is an improvement.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/238880686616664","repostId":"1132071850","repostType":2,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":340623523848440,"gmtCreate":1724202206089,"gmtModify":1724202233214,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLOV\">$Clover Health Corp(CLOV)$</a>&nbsp; Bullish","listText":"<a href=\"https://ttm.financial/S/CLOV\">$Clover Health Corp(CLOV)$</a>&nbsp; Bullish","text":"$Clover Health Corp(CLOV)$ Bullish","images":[{"img":"https://community-static.tradeup.com/news/3884807ec615526a70577bd7facc5686","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/340623523848440","isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":335496080683016,"gmtCreate":1722944384940,"gmtModify":1722951516614,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine&nbsp;","listText":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine&nbsp;","text":"This counter has probably gone under the radar by many investors. Been following it for 2 years, it's a gem waiting to shine","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/335496080683016","repostId":"2457089410","repostType":2,"repost":{"id":"2457089410","kind":"highlight","pubTimestamp":1722904917,"share":"https://ttm.financial/m/news/2457089410?lang=&edition=fundamental","pubTime":"2024-08-06 08:41","market":"hk","language":"en","title":"Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2457089410","media":"seekingalpha","summary":"Clover Health Investments  pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance. The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.  Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/CLOV\">Clover Health Investments</a> pleased investors after Monday&#39;s closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.</p><p>Shares of Clover Health gained over 2% in extended trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5a9c5d84fe8a57d68592d976038341cf\" tg-width=\"847\" tg-height=\"621\"/></p><p>The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.</p><p>Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Health Boosts 2024 Insurance Revenue Outlook, Lowers Medical Cost Ratio Range\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-06 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.Shares of Clover ...</p>\n\n<a href=\"https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp","BK4547":"WSB热门概念","BK4154":"管理型保健护理"},"source_url":"https://seekingalpha.com/news/4134517-clover-health-boosts-2024-insurance-revenue-outlook-lowers-medical-cost-ratio-range","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2457089410","content_text":"Clover Health Investments pleased investors after Monday's closing bell by not only releasing Q2 results that beat on both lines, but also providing favorable updated 2024 guidance.Shares of Clover Health gained over 2% in extended trading.The Medicare Advantage plan provider now sees full-year insurance revenue guidance of $1.35B-$1.375B up from $1.3B-$1.35B before. The medical cost ratio for 2024 is now expected at 77%-79%, down from 79%-81% prior.Clover Health was helped in the quarter by an 11% year-over-year increase in total revenue to $356.3M, as well as a medical cost ratio of 71.3%, compared to 77.2% in the year ago period.","news_type":1},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":332074973077536,"gmtCreate":1722080926059,"gmtModify":1722086434655,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"It's just another day to buy the dip","listText":"It's just another day to buy the dip","text":"It's just another day to buy the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/332074973077536","isVote":1,"tweetType":1,"viewCount":271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":238880686616664,"gmtCreate":1699349660119,"gmtModify":1699350799142,"author":{"id":"4143078149508732","authorId":"4143078149508732","name":"NinjaDaddy","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4143078149508732","authorIdStr":"4143078149508732"},"themes":[],"htmlText":"Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m.&nbsp; The revision is an improvement.&nbsp;","listText":"Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m.&nbsp; The revision is an improvement.&nbsp;","text":"Just to comment this is a crap article. negative 55 to 80 million is better than negative 70 to 120m. The revision is an improvement.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/238880686616664","repostId":"1132071850","repostType":2,"repost":{"id":"1132071850","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1699349407,"share":"https://ttm.financial/m/news/1132071850?lang=&edition=fundamental","pubTime":"2023-11-07 17:30","market":"us","language":"en","title":"Clover Health Tanks 12% As Healthcare Provider Q3 Sales Miss Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=1132071850","media":"Tiger Newspress","summary":"Clover Health Investments reported quarterly sales of $482.07 million which missed the analyst consensus estimate of $494.60 million by 2.53 percent. This is a 43.74 percent decrease over sales of $856.82 million the same period last year.Clover Health shares tanked 12% in premarket trading Tuesday.Clover Health, a renowned healthcare provider, has recently made a significant revision to its projected 2023 Adjusted EBITDA outlook. As of November 6, 2023, the company has adjusted its estimated ea","content":"<html><head></head><body><p>Clover Health Investments reported quarterly sales of $482.07 million which missed the analyst consensus estimate of $494.60 million by 2.53 percent. This is a 43.74 percent decrease over sales of $856.82 million the same period last year.</p><p>Clover Health shares tanked 12% in premarket trading Tuesday.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fa00d9950989427ecd7be5e557a3d8ee\" tg-width=\"841\" tg-height=\"618\"/></p><p>Clover Health, a renowned healthcare provider, has recently made a significant revision to its projected 2023 Adjusted EBITDA outlook. As of November 6, 2023, the company has adjusted its estimated earnings before interest, taxes, depreciation, and amortization to a range of ($55) million – ($80) million. This revision comes as a surprise, as it signifies a potential decrease in expected profitability for Clover Health in the upcoming year.</p><p style=\"text-align: start;\">The revised outlook highlights the challenges that Clover Health may face in achieving its financial goals for 2023. While the previous range had projected earnings between ($70) million – ($120) million, the revised figures indicate a potential decline in profitability. This adjustment serves as a cautionary signal for investors and stakeholders, urging them to reassess their expectations for the company’s financial performance.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Health Tanks 12% As Healthcare Provider Q3 Sales Miss Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Health Tanks 12% As Healthcare Provider Q3 Sales Miss Estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2023-11-07 17:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Clover Health Investments reported quarterly sales of $482.07 million which missed the analyst consensus estimate of $494.60 million by 2.53 percent. This is a 43.74 percent decrease over sales of $856.82 million the same period last year.</p><p>Clover Health shares tanked 12% in premarket trading Tuesday.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fa00d9950989427ecd7be5e557a3d8ee\" tg-width=\"841\" tg-height=\"618\"/></p><p>Clover Health, a renowned healthcare provider, has recently made a significant revision to its projected 2023 Adjusted EBITDA outlook. As of November 6, 2023, the company has adjusted its estimated earnings before interest, taxes, depreciation, and amortization to a range of ($55) million – ($80) million. This revision comes as a surprise, as it signifies a potential decrease in expected profitability for Clover Health in the upcoming year.</p><p style=\"text-align: start;\">The revised outlook highlights the challenges that Clover Health may face in achieving its financial goals for 2023. While the previous range had projected earnings between ($70) million – ($120) million, the revised figures indicate a potential decline in profitability. This adjustment serves as a cautionary signal for investors and stakeholders, urging them to reassess their expectations for the company’s financial performance.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132071850","content_text":"Clover Health Investments reported quarterly sales of $482.07 million which missed the analyst consensus estimate of $494.60 million by 2.53 percent. This is a 43.74 percent decrease over sales of $856.82 million the same period last year.Clover Health shares tanked 12% in premarket trading Tuesday.Clover Health, a renowned healthcare provider, has recently made a significant revision to its projected 2023 Adjusted EBITDA outlook. As of November 6, 2023, the company has adjusted its estimated earnings before interest, taxes, depreciation, and amortization to a range of ($55) million – ($80) million. This revision comes as a surprise, as it signifies a potential decrease in expected profitability for Clover Health in the upcoming year.The revised outlook highlights the challenges that Clover Health may face in achieving its financial goals for 2023. While the previous range had projected earnings between ($70) million – ($120) million, the revised figures indicate a potential decline in profitability. This adjustment serves as a cautionary signal for investors and stakeholders, urging them to reassess their expectations for the company’s financial performance.","news_type":1},"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}